Hi Hercules, sola = solanezumab.
The trial is to try to target people earlier in the disease process. Will be interesting to see what happens to sola if PBT2 knocks it out of the park..! (Fingers crossed)
- Forums
- ASX - By Stock
- ATH
- nejm solanezumab
nejm solanezumab, page-7
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $625 | 125K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
63 | 72318906 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 29668676 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
63 | 72318906 | 0.004 |
47 | 46805652 | 0.003 |
18 | 41489402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 29668676 | 22 |
0.006 | 34264749 | 14 |
0.007 | 17220649 | 15 |
0.008 | 14174718 | 13 |
0.009 | 6000000 | 5 |
Last trade - 10.00am 09/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |